Accelerated evolution and spread of multidrug-resistant Plasmodium falciparum takes down the latest first-line antimalarial drug in southeast Asia.
作者信息
Ménard Didier, Fidock David A
机构信息
Biology of Host-Parasite Interactions Unit, Malaria Genetics and Resistance Group, Institut Pasteur, INSERM U1201, CNRS ERL9195, Paris, France.
Department of Microbiology and Immunology, and Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
出版信息
Lancet Infect Dis. 2019 Sep;19(9):916-917. doi: 10.1016/S1473-3099(19)30394-9. Epub 2019 Jul 22.
Abstract
摘要
相似文献
1
Accelerated evolution and spread of multidrug-resistant Plasmodium falciparum takes down the latest first-line antimalarial drug in southeast Asia.
Lancet Infect Dis. 2019 Sep;19(9):916-917. doi: 10.1016/S1473-3099(19)30394-9. Epub 2019 Jul 22.
2
Emergence of multidrug-resistant Plasmodium falciparum in Thailand: in vitro tracking.
Am J Trop Med Hyg. 1992 Jul;47(1):112-6. doi: 10.4269/ajtmh.1992.47.112.
3
The threat of artemisinin resistant malaria in Southeast Asia.
Travel Med Infect Dis. 2016 Nov-Dec;14(6):548-550. doi: 10.1016/j.tmaid.2016.11.016. Epub 2016 Nov 30.
4
Treatment of malaria acquired in Southeast Asia.
Mil Med. 1992 Jan;157(1):4-6.
5
The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.
FEMS Microbiol Rev. 2017 Jan;41(1):34-48. doi: 10.1093/femsre/fuw037. Epub 2016 Sep 8.
6
Fake artesunate in southeast Asia.
Lancet. 2001 Jun 16;357(9272):1948-50. doi: 10.1016/S0140-6736(00)05085-6.
7
Artemisinin Resistance in Southeast Asia.
Clin Infect Dis. 2016 Dec 1;63(11):1527. doi: 10.1093/cid/ciw583. Epub 2016 Aug 23.
8
Intercontinental spread of pyrimethamine-resistant malaria.
Science. 2004 Aug 20;305(5687):1124. doi: 10.1126/science.1098876.
9
Clinical management of chloroquine-resistant Plasmodium falciparum malaria in Southeast Asia.
Trop Doct. 1983 Oct;13(4):153-8. doi: 10.1177/004947558301300405.
10
Molecular detection of drug resistant malaria in Southern Thailand.
Malar J. 2019 Aug 15;18(1):275. doi: 10.1186/s12936-019-2903-y.
引用本文的文献
1
Global trends, health inequalities, and projections in the burden of neglected tropical diseases and malaria from 1990 to 2021.
Sci Rep. 2025 Jul 1;15(1):20958. doi: 10.1038/s41598-025-05530-y.
2
Characterization of the malaria parasite Tepsin homolog.
Microbiol Spectr. 2025 Aug 5;13(8):e0328824. doi: 10.1128/spectrum.03288-24. Epub 2025 Jun 30.
3
Lysine targeting covalent inhibitors of malarial kinase CLK3.
RSC Med Chem. 2025 May 27. doi: 10.1039/d5md00335k.
4
YAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolates.
Sci Rep. 2025 Jan 23;15(1):2941. doi: 10.1038/s41598-025-85346-y.
5
Strong positive selection biases identity-by-descent-based inferences of recent demography and population structure in Plasmodium falciparum.
Nat Commun. 2024 Mar 20;15(1):2499. doi: 10.1038/s41467-024-46659-0.
6
A pH Fingerprint Assay to Identify Inhibitors of Multiple Validated and Potential Antimalarial Drug Targets.
ACS Infect Dis. 2024 Apr 12;10(4):1185-1200. doi: 10.1021/acsinfecdis.3c00588. Epub 2024 Mar 18.
7
Strong Positive Selection Biases Identity-By-Descent-Based Inferences of Recent Demography and Population Structure in .
bioRxiv. 2023 Jul 15:2023.07.14.549114. doi: 10.1101/2023.07.14.549114.
8
In vitro activity of rhinacanthin analogues against drug resistant Plasmodium falciparum isolates from Northeast Thailand.
Malar J. 2023 Mar 23;22(1):105. doi: 10.1186/s12936-023-04532-3.
9
Overdiagnosis and overuse of diagnostic and screening tests in low-income and middle-income countries: a scoping review.
BMJ Glob Health. 2022 Oct;7(10). doi: 10.1136/bmjgh-2022-008696.
10
A G358S mutation in the Plasmodium falciparum Na pump PfATP4 confers clinically-relevant resistance to cipargamin.
Nat Commun. 2022 Sep 30;13(1):5746. doi: 10.1038/s41467-022-33403-9.
本文引用的文献
1
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.
Lancet Infect Dis. 2019 Sep;19(9):952-961. doi: 10.1016/S1473-3099(19)30391-3. Epub 2019 Jul 22.
2
Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study.
Lancet Infect Dis. 2019 Sep;19(9):943-951. doi: 10.1016/S1473-3099(19)30392-5. Epub 2019 Jul 22.
3
Elucidating Mechanisms of Drug-Resistant Plasmodium falciparum.
Cell Host Microbe. 2019 Jul 10;26(1):35-47. doi: 10.1016/j.chom.2019.06.001.
4
Pyronaridine-artesunate Efficacy and Safety in Uncomplicated Plasmodium falciparum Malaria in Areas of Artemisinin-resistant Falciparum in Viet Nam (2017-2018).
Clin Infect Dis. 2020 May 6;70(10):2187-2195. doi: 10.1093/cid/ciz580.
5
Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine.
Nat Commun. 2018 Aug 17;9(1):3314. doi: 10.1038/s41467-018-05652-0.
6
Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study.
Lancet Infect Dis. 2018 Mar;18(3):337-345. doi: 10.1016/S1473-3099(18)30068-9. Epub 2018 Feb 2.
7
Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity.
J Infect Dis. 2017 Aug 15;216(4):468-476. doi: 10.1093/infdis/jix334.
8
Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam.
Emerg Infect Dis. 2017 Apr;23(4):715-717. doi: 10.3201/eid2304.161872.
9
Antimalarial Drug Resistance: A Threat to Malaria Elimination.
Cold Spring Harb Perspect Med. 2017 Jul 5;7(7):a025619. doi: 10.1101/cshperspect.a025619.
10
Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors.
Clin Infect Dis. 2016 Sep 15;63(6):784-791. doi: 10.1093/cid/ciw388. Epub 2016 Jun 16.
Zotero 插件